Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
First Capital S.p.A. ( (IT:FIC) ) has provided an update.
First Capital S.p.A. has announced the establishment of V.F. Pharma S.r.l., a new investment vehicle dedicated to Più Medical S.p.A., in collaboration with La Farmaceutica S.p.A. and GSM S.r.l. This initiative is part of First SICAF’s strategy to support Più Medical’s growth and expansion in the retail pharmacy sector. V.F. Pharma now holds a significant stake in Più Medical, with First SICAF owning 51% of V.F. Pharma. This move reflects First Capital’s confidence in Più Medical’s growth prospects and aligns with its long-term partnership strategy.
The most recent analyst rating on (IT:FIC) stock is a Buy with a EUR30.40 price target. To see the full list of analyst forecasts on First Capital S.p.A. stock, see the IT:FIC Stock Forecast page.
More about First Capital S.p.A.
First Capital S.p.A. is a financial holding company specializing in Private Investments in Public Equity and Private Equity investments, focusing on small and medium-sized listed companies. The company aims to identify investment opportunities in market-leading companies with sustainable development plans and proven management capabilities, employing an active management approach.
Average Trading Volume: 6,543
Technical Sentiment Signal: Buy
Current Market Cap: €76.63M
Find detailed analytics on FIC stock on TipRanks’ Stock Analysis page.